Last reviewed · How we verify
Squamous non-small cell lung cancer
Approved treatments
- Portrazza · Eli Lilly Co
Portrazza works by blocking the epidermal growth factor receptor (EGFR) protein, which is involved in cancer cell growth and proliferation.
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Squamous non-small cell lung cancer patent landscape — cliff calendar, originator estates, attackable patents
- Squamous non-small cell lung cancer treatment landscape brief
- Squamous non-small cell lung cancer treatment updates RSS
Frequently asked questions about Squamous non-small cell lung cancer
What drugs treat Squamous non-small cell lung cancer?
Tracked treatments include Portrazza.
What is the treatment for Squamous non-small cell lung cancer?
Standard treatment for Squamous non-small cell lung cancer includes Portrazza. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Squamous non-small cell lung cancer patent cliff · Squamous non-small cell lung cancer CI report
- Treatment: Portrazza · Eli Lilly Co
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing